News|Articles|December 8, 2025
Low-ng/mL quantitation of glucagon-like peptide-1 (GLP-1) analog in rat plasma
Author(s)SCIEX
This technical note demonstrates a sensitive method to quantify a glucagon-like peptide-1 (GLP-1) analog, semaglutide, in rat plasma on a high-end triple quadrupole mass spectrometer.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
How FDA’s Bayesian Guidance Could Accelerate Adaptive Trial Design in Biopharmaceuticals
2
Novartis Calls for Global Governments to Address Global Trade Policy
3
Generative AI and Adaptive Trials Shape Future Biotech Development
4
Executive Summary: From Molecule to Formulation: A Systematic Approach to Assess Biologics Developability
5